{"id":13658,"date":"2025-10-14T12:59:31","date_gmt":"2025-10-14T10:59:31","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=13658"},"modified":"2025-11-26T21:39:51","modified_gmt":"2025-11-26T19:39:51","slug":"kasvajaantigeen-s-100-s-s-100","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/","title":{"rendered":"Kasvajaantigeen S-100 (S-S-100)"},"content":{"rendered":"\n<p><em>Kliinilise keemia osakond, tel. 731 8316<\/em><\/p>\n\n\n\n<p><strong>S-100<\/strong> on madalmolekulaarne kaltsiumi siduv valk, millel on praeguseks teada 21 erinevat alat\u00fc\u00fcpi. S-100 esineb tavaliselt dimeerina, koosnedes kahest ahelast. S-100 f\u00fcsioloogiline roll ei ole selge. Kliinilises diagnostikas kasutatakse alat\u00fc\u00fcbi S-100B (S-100A1B ja S-100BB) m\u00e4\u00e4ramist. S-100B s\u00fcnteesitakse peamiselt keskn\u00e4rvis\u00fcsteemi, eriti astrogliia ja Schwanni rakkude, kuid ka maliigse melanoomi rakkude poolt.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"15%\"><strong>Katsuti<\/strong><\/td><td width=\"84%\">Geeli ja h\u00fc\u00fcbimisaktivaatoriga katsuti (kollane kork)<\/td><\/tr><tr><td><\/td><td><strong>S\u00e4ilivus<\/strong><\/td><td>Seerum toatemperatuuril kaheksa tundi, +4 \u00b0C kaks p\u00e4eva, -20 \u00b0C kolm kuud<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsi tegemise aeg:<\/strong> t\u00f6\u00f6p\u00e4eviti<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsimeetod: <\/strong>elektrokemoluminestsents-immuunmeetod (ECLIA)<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Referentsv\u00e4\u00e4rtused<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"30%\"><strong>\u2265 18 a<\/strong><\/td><td width=\"69%\">\u2264 0,105 \u03bcg\/L<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>N\u00e4idustus ja kliiniline t\u00e4hendus<\/strong><\/p>\n\n\n\n<p>Melanoomiga patsientide haiguskulu ja ravi j\u00e4lgimine.<\/p>\n\n\n\n<p>Soovitatav monitooringu sagedus p\u00e4rast operatiivset ravi \u00fcle 1 mm paksuste (Breslow j\u00e4rgi) tuumorite puhul: esimesed viis aastat iga kolme kuu tagant, 6.-10. aastal iga kuue kuu tagant. Postoperatiivne S-100 sisalduse suurenemine viitab metastaaside tekkele. S-100 korduv m\u00e4\u00e4ramine v\u00f5imaldab j\u00e4lgida ka ravi efektiivsust (soovitatav monitooringu sagedus kord kuus).<\/p>\n\n\n\n<p>Kerge peatraumaga patsientide k\u00e4sitlemine.<\/p>\n\n\n\n<p>Suurenenud S-100 kontsentratsiooni v\u00f5ib t\u00e4heldada erinevate ajukahjustuse liikide, eelk\u00f5ige ajutraumade korral. Referentsv\u00e4\u00e4rtuste piires olev S-100 kontsentratsioon v\u00f5imaldab traumaatilise ajukahjustuse olemasolu suure t\u00f5en\u00e4osusega v\u00e4lja l\u00fclitada (negatiivne ennustusj\u00f5ud 99,7%). Tingituna S-100 l\u00fchikesest poolestusajast (1,5 h) tuleks proov v\u00f5tta kolme tunni jooksul p\u00e4rast traumat.<\/p>\n\n\n\n<p>Koostaja: Katrin Reimand<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kliinilise keemia osakond, tel. 731 8316 S-100 on madalmolekulaarne kaltsiumi siduv valk, millel on praeguseks teada 21 erinevat alat\u00fc\u00fcpi. S-100 esineb tavaliselt dimeerina, koosnedes kahest ahelast. S-100 f\u00fcsioloogiline roll ei ole selge. Kliinilises diagnostikas kasutatakse alat\u00fc\u00fcbi S-100B (S-100A1B ja S-100BB) m\u00e4\u00e4ramist. S-100B s\u00fcnteesitakse peamiselt keskn\u00e4rvis\u00fcsteemi, eriti astrogliia ja Schwanni rakkude, kuid ka maliigse melanoomi rakkude [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":7280,"menu_order":13,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-13658","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Kliinilise keemia osakond, tel. 731 8316 S-100 on madalmolekulaarne kaltsiumi siduv valk, millel on praeguseks teada 21 erinevat alat\u00fc\u00fcpi. S-100 esineb tavaliselt dimeerina, koosnedes kahest ahelast. S-100 f\u00fcsioloogiline roll ei ole selge. Kliinilises diagnostikas kasutatakse alat\u00fc\u00fcbi S-100B (S-100A1B ja S-100BB) m\u00e4\u00e4ramist. S-100B s\u00fcnteesitakse peamiselt keskn\u00e4rvis\u00fcsteemi, eriti astrogliia ja Schwanni rakkude, kuid ka maliigse melanoomi rakkude [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-26T19:39:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/kasvajaantigeen-s-100-s-s-100\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/kasvajaantigeen-s-100-s-s-100\\\/\",\"name\":\"Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2025-10-14T10:59:31+00:00\",\"dateModified\":\"2025-11-26T19:39:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/kasvajaantigeen-s-100-s-s-100\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/kasvajaantigeen-s-100-s-s-100\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/kasvajaantigeen-s-100-s-s-100\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kasvajamarkerite uuringud\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/kasvajamarkerite-uuringud\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Kasvajaantigeen S-100 (S-S-100)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/","og_locale":"et_EE","og_type":"article","og_title":"Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor","og_description":"Kliinilise keemia osakond, tel. 731 8316 S-100 on madalmolekulaarne kaltsiumi siduv valk, millel on praeguseks teada 21 erinevat alat\u00fc\u00fcpi. S-100 esineb tavaliselt dimeerina, koosnedes kahest ahelast. S-100 f\u00fcsioloogiline roll ei ole selge. Kliinilises diagnostikas kasutatakse alat\u00fc\u00fcbi S-100B (S-100A1B ja S-100BB) m\u00e4\u00e4ramist. S-100B s\u00fcnteesitakse peamiselt keskn\u00e4rvis\u00fcsteemi, eriti astrogliia ja Schwanni rakkude, kuid ka maliigse melanoomi rakkude [&hellip;]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/","og_site_name":"\u00dchendlabor","article_modified_time":"2025-11-26T19:39:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/","name":"Kasvajaantigeen S-100 (S-S-100) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2025-10-14T10:59:31+00:00","dateModified":"2025-11-26T19:39:51+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/kasvajaantigeen-s-100-s-s-100\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"Kasvajamarkerite uuringud","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/kasvajamarkerite-uuringud\/"},{"@type":"ListItem","position":4,"name":"Kasvajaantigeen S-100 (S-S-100)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kadi Siigur","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kadisi\/"},"uagb_comment_info":0,"uagb_excerpt":"Kliinilise keemia osakond, tel. 731 8316 S-100 on madalmolekulaarne kaltsiumi siduv valk, millel on praeguseks teada 21 erinevat alat\u00fc\u00fcpi. S-100 esineb tavaliselt dimeerina, koosnedes kahest ahelast. S-100 f\u00fcsioloogiline roll ei ole selge. Kliinilises diagnostikas kasutatakse alat\u00fc\u00fcbi S-100B (S-100A1B ja S-100BB) m\u00e4\u00e4ramist. S-100B s\u00fcnteesitakse peamiselt keskn\u00e4rvis\u00fcsteemi, eriti astrogliia ja Schwanni rakkude, kuid ka maliigse melanoomi rakkude&hellip;","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/13658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=13658"}],"version-history":[{"count":0,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/13658\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7280"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=13658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}